Oropouche Fever -An Emerging Public Health Concern in Tropical Regions
Abstract
Oropouche fever is an emerging infectious disease caused by the Oropouche virus and has become an increasing concern for public health. The virus is spreading more widely across regions, influenced by environmental, social, and ecological factors such as climate change, urbanization, and vector distribution. Its symptoms-fever, headache, muscle pain, and fatigue-closely resemble those of other Arboviruses, making accurate diagnosis essential for effective management and prevention. The disease is transmitted mainly through insect vectors, particularly biting midges and mosquitoes, which play a key role in viral proliferation. Once inside the human body, the virus invades host cells and triggers immune responses that contribute to symptom development. In some cases, severe complications may arise, including neurological effects, death, and risks to unborn babies, highlighting the need for timely detection. Diagnosing Oropouche fever remains challenging due to symptom overlap with other infections. Current Diagnostic methods, including serological and molecular techniques, have limitations in accuracy, availability, and accessibility, especially in low-resource settings. As a result, misdiagnosis is common. There are no specific antiviral drugs or approved vaccines available, so Supportive care remains the primary approach to patient management. Strengthening Disease surveillance, improving diagnostic tools, and developing vaccines are crucial steps in controlling the spread of OROV and reducing its impact on affected populations.
Downloads
References
2. Okesanya OJ, et al. Addressing the emerging threat of Oropouche virus: implications and public health responses for healthcare systems. Trop Dis Travel Med Vaccines. 2025 Jan;11(1):1. doi:10.1186/s40794-024-00236-x.
3. Romero-Alvarez D, Manore CA. The foretold Oropouche fever epidemic. Lancet Infect Dis. 2025 Apr:S1473309925001653. doi:10.1016/S1473-3099(25)00165-3.
4. Salvato RS. Re-emergence of Oropouche virus as a novel global threat. Curr Res Microb Sci. 2025;8:100406. doi:10.1016/j.crmicr.2025.100406.
5. Sakkas H, et al. Oropouche fever: a review. Viruses. 2018 Apr;10(4):175. doi:10.3390/v10040175.
6. Labiod N, et al. Oropouche virus, a new emerging threat. Curr Infect Dis Rep. 2025 Dec;27(1):13. doi:10.1007/s11908-025-00862-2.
7. Wang Z, et al. Clinical presentation of Oropouche virus infection: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2025 Apr;19(4):e0012962. doi:10.1371/journal.pntd.0012962.
8. Sah R, et al. Neurological manifestations in Oropouche virus infection: a systematic review and meta-analysis. J Med Virol. 2025 Aug;97(8):e70532. doi:10.1002/jmv.70532.
9. Guagliardo SAJ, et al. Estimation of incubation period for Oropouche virus disease among travel-associated cases, 2024–2025. Emerg Infect Dis. 2025 Jul;31(7). doi:10.3201/eid3107.250468.
10. Patel SK, et al. The Oropouche virus (OROV) and need of advanced diagnostics to mitigate it. Ann Med Surg. 2025 Apr;87(4):2516–17. doi:10.1097/MS9.0000000000003131.
11. Porwal S, et al. Mysterious Oropouche virus: transmission, symptoms, and control. Infect Med. 2025 Jun;4(2):100177. doi:10.1016/j.imj.2025.100177.
12. Yoosuf BT, et al. Epidemiology, transmission dynamics, treatment strategies, and future perspectives on Oropouche virus. Diagn Microbiol Infect Dis. 2025 Sep;113(1):116882. doi:10.1016/j.diagmicrobio.2025.116882.
13. Gupta H, et al. A comprehensive overview of the burden, prevention, and therapeutic aspects of arboviral diseases in India. Commun Med. 2025 Jul;5(1):254. doi:10.1038/s43856-025-00968-7.
14. Santos SCF, et al. Understanding the emergence, expansion, and impact of Oropouche virus. Discov Viruses. 2025 Jul;2(1). doi:10.1007/s44370-025-00021-0.
15. Rodriguez-Morales AJ, et al. Challenges in emerging and reemerging arboviral diseases: the examples of Oropouche and yellow fever. Pathogens. 2025 Jun;14(7):621. doi:10.3390/pathogens14070621.
16. Lorenz C, et al. Oropouche fever outbreak in Brazil: key factors behind the largest epidemic in history. PLoS One. 2025 Jul;20(7):e0327845. doi:10.1371/journal.pone.0327845.
17. Diemert DJ, et al. A randomized, controlled phase 1b trial of the Sm-TSP-2 vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area. PLoS Negl Trop Dis. 2023 Mar;17(3):e0011236. doi:10.1371/journal.pntd.0011236.
18. Gallichotte EN, et al. Vector competence for Oropouche virus: a systematic review of pre-2024 experiments. PLoS Negl Trop Dis. 2025;19(4):e0013014. doi:10.1371/journal.pntd.0013014
19. Fischer C, et al. The spatiotemporal ecology of Oropouche virus across Latin America: a multidisciplinary, laboratory-based, modelling study. Lancet Infect Dis. 2025;25(9):1020–1032. doi:10.1016/S1473-3099(25)00110-0

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

.